Get started
Live feed
SECFilingvia Quantisnow
Telomir Pharmaceuticals Inc. logo

TELO: Telomir Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for TELO

Across the 17 sessions after earlier TELO headlines, the stock closed higher 10 times and lower 6 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

TELO close-to-close change in the session after earlier headlines
SessionEarlier headlineTELOSPY
Sep 17, 2026Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)-0.9%+1.1%
Sep 14, 2026Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models+0.0%-0.4%
Aug 10, 2026Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models+0.9%-0.0%
Jun 15, 2026Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model+2.4%+1.8%
May 20, 2026Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease+7.4%+1.0%
Apr 30, 2026Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer-3.4%+1.0%
Quantisnow market dataNASDAQ
Telomir Pharmaceuticals Inc. logo
TELO
Telomir Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2024
Get push alerts for TELO

Follow TELO and get a push notification the moment its next story breaks.

Full TELO profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TELO (Telomir Pharmaceuticals Inc.) and more on Quantisnow.